Amarin Corp Plc (AMRN)

[heysfguy]

the timing of the recent study couldn't be better. It's like AMRN is building its case both inside and outside the courtroom, getting out of the FDA chokehold. Classic reversal in wrestling terms. At this point it appears (IMO) that if the FDA isn't talking major compromises this is going to the courtroom. and we all know the GDA's reluctance to settle.